HBIO
Harvard Bioscience, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$8.02
+0.25%Margins
Gross margin
58.2%
EBITDA margin
-1.1%
EBIT margin
1.2%
Net margin
-11.9%
FCF margin
-1.6%
-140.4%
Return on equity
-13.6%
Return on assets
2.0%
Return on invested capital
1.14x
Asset turnover
$649.0K
Cash from operations
$1.43
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026